News > Johnson & Johnson plans to test its Covid-19 vaccine in ages 12-18 soon

Johnson & Johnson plans to test its Covid-19 vaccine in ages 12-18 soon

“We plan to go into children as soon as we possibly can, but very carefully in terms of safety,” J&J’s Dr Jerry Sadoff told a virtual meeting of the CDC’s Advisory Committee on Immunization Practices.

J&J started testing the vaccine in adults in a 60,000-volunteer Phase III study in late September. It had to pause the trial earlier this month because of a serious medical event in one participant. The study resumed last week.